首页 | 本学科首页   官方微博 | 高级检索  
检索        

瘀痛消胶囊对大鼠实验性肝纤维化影响的实验研究
引用本文:徐志新,韦艾凌,魏录翠.瘀痛消胶囊对大鼠实验性肝纤维化影响的实验研究[J].广西中医药,2006,29(2):51-53.
作者姓名:徐志新  韦艾凌  魏录翠
作者单位:1. 广西中医学院第一附属医院,530023,南宁市园湖路2号
2. 广西中医学院,530001
摘    要:目的:观察瘀痛消胶囊对大鼠实验性肝纤维化的影响。方法:采用复合因素诱导大鼠肝纤维化模型。Wistar大鼠随机分为正常组、瘀痛消胶囊组、疏肝理脾片组、模型组。瘀痛消胶囊组和疏肝理脾片组在造模的同时给药,造模结束后观察各组肝纤维化程度及血清谷丙转氨酶(ALT)、透明质酸(HA)的变化。结果:瘀痛消胶囊组纤维化程度低于模型组(P<0.01);瘀痛消胶囊组的血清HA、ALT均较模型组有明显下降(P<0.01)。结论:瘀痛消胶囊具有一定的抗大鼠实验性肝纤维化的作用。

关 键 词:肝纤维化  瘀痛消胶囊  大鼠  实验研究
文章编号:1003-0719(2006)02-0051-03
收稿时间:2005-11-24
修稿时间:2005-11-24

Experimental Research on Effect of YuTongXiao Capsule on Experimental Hepatic Fibrosis in Rats
Xu Zhixin,Wei Ailing,Wei Lucui.Experimental Research on Effect of YuTongXiao Capsule on Experimental Hepatic Fibrosis in Rats[J].Guangxi Journal of Traditional Chinese Medicine,2006,29(2):51-53.
Authors:Xu Zhixin  Wei Ailing  Wei Lucui
Institution:The First Affiliated Hospital, Guangxi TCM University Narming 530001 Wei Lucui Guangxi TCM University Nanning 530001
Abstract:Objective: To observe the effects of YuTongXiao Capsule on experimental hepatic fibrosis in rats. Methods: The Wistar rats were made into moedels by comprehensive pathogens, and then randomly divided into the control group, the YuTongXiao Capsule group, the smoothing liver and regulating spleen group, and the model group. During this process, the treatment was given to the YuTongXiao Capsule group and the smoothing liver and regulating spleen group. Then the observation was made to see the degree of hepatic fibrosis and the change of ALT and HA in each group. Results: When compared with the model group, the degree of hepatic fibrosis in the YuTongXiao Capsule group was lower (P<0.01); meanwhile, HA and ALT were lowered obviously (P<0.001). Conclusion: YuTongXiao Capsule has effects on anti experimental hepatic fibrosis in rats.
Keywords:Hepatic fibrosis  YuTongXiao Capsule  Wistar rats  experimental research
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号